GlobalData forecasts the hepatitis B therapeutics market will more than double to $3.2B by 2034, driven by functional cure ...
The Handmaid's Tale cast is booked and busy with new projects — including the Testaments spinoff — after the Hulu series came ...
Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...
Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
With Hulu’s recent announcement that The Handmaid’s Tale spin-off series The Testaments will make its debut in April of 2026, ...